Targets

Therapy methods

Vismodegib
Mitomysin + Cyclopamine
Oxaliplatin + Cyclopamine
KI20227
Imatinib Mesylate
Carfilzomib + Vismodegib
Carfilzomib + Reversin 121
Repertaxin
Metformin
Quercetin
Trastuzumab
Trastuzumab + XL147
Lapatinib
DFMO
LDN193189
Trastuzumab emtansine
YK-4-279
CDF
DZNeP
DZNeP + Gemcitabine
Back to top